The increase in life span of the American population over

Size: px
Start display at page:

Download "The increase in life span of the American population over"

Transcription

1 Ten-Year Experience f Cardiac Surgery in Patients Aged 80 Years and Over Tsung-P Tsai, MD, Aureli Chaux, MD, Jack M. Matlff, MD, Rbert M. Kass, MD, Richard J. Gray, MD, Michele A. DeRbertis, RN, and Steven S. Khan, MD Department f Cardithracic Surgery, Cedars-Sinai Medical Center, Ls Angeles, Califrnia Five hundred twenty-eight cnsecutive patients aged 80 years and ver (mean age, 8.1 ±.7 years) underwent cardiac peratins with hypthermia (mean, 1.9 ±. C), hyperkalemic cardiplegia, and cardipulmnary bypass in a -year perid. Fifty-six percent f the patients were male. Preperatively, 68% f the patients were in New Yrk Heart Assciatin functinal class IV, and 1% were in class III. Amng them, 0 patients had islated crnary artery bypass grafting (CABG) (grup I), 1 had artic valve replacement nly r cmbined with CABG (grup 11), 4 had mitral valve replacement nly r cmbined with CABG (grup 111), 1 had mitral valve repair and CABG (grup IV), and 0 had dublevalve prcedure nly r cmbined with CABG (grup V). The 0-day r in-hspital mrtality was 8.% in grup I, 4.% in grup II, 9% in grup III, % in grup IV, and 0% in grup V. Ttal0-day r in-hspital mrtality was.6%. One-year and -year actuarial survival rates were as fllws: grup I, 8% and 6%; grup II, 8% and 8%; grup III, 61% and 7%; grup IV, 6% and 19%; and grup V, 6% and 1%. Ttall-year and -year actuarial survival were 79% and 4%. At fllw-up (mean, years), 70% f verall survivrs reprted that their general health had imprved. Our experience demnstrates that fr select patients aged 80 years and ver with unmanageable cardiac symptms, CABG and artic valve replacement grups had better results in imprving quality f life as cmpared with patients having mitral r cmbined prcedures. (Ann Thme Surg 1994;8:44-1) The increase in life span f the American ppulatin ver the past decade has resulted in a significant increase in the number f peple aged mre than 80 years. Based n statistical data derived frm ppulatin studies, life expectancy varies frm an average f apprximately 8.1 years at the age f 80 years t 6.0 years at the age f 89 years [1]. In 1990, 7.4 millin Americans, representing % f the ppulatin, were mre than 80 years f age. Of these ctgenarians, % have serius symptmatic heart disease, including 18% with ischemic heart disease []. Octgenarians with significant symptms f cardivascular disease frequently are referred fr peratin t try t imprve their quality f life. Recent reprts reveal that cardiac peratins fr selected elderly individuals wh have therwise gd physical and mental health can imprve mrtality, mrbidity, and even quality f life [-9]. Hwever, the utcmes remain prly defined, especially fr valve and cmbined prcedures. This reprt describes the results f mycardial revascularizatin and valve prcedures in patients aged 80 years and lder by examining ur -year experience. Material and Methds There were 8 patients lder than 80 years wh underwent cardiac peratins with hypthermic cardipulmnary bypass between June 198 and Octber 199. Age Accepted fr publicatin Nv 9, 199. Address reprint rel..luests t Dr Tsai, Department fcardithracic Surgery, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Rm 61, Ls Angeles, CA by The Sciety f Thracic Surgens ranged frm 80 t 94 years, with a mean f 8.1 ::':::.7 years. Fifty-six percent f the patients were male. Preperatively, 68% f the patients were in New Yrk Heart Assciatin functinal class IV and 1% were in class III. Frty-six percent f the patients had severe triple-vessel crnary artery disease and 6% had left main stensis. Mst patients presented with acute cardivascular symptms: 70% had unstable prgressive angina pectris, 69% f the patients experienced dyspnea, 4% had a histry f chrnic angina pectris, % had abnrmal exercise test, and % experienced syncpe. Sixty percent f the patients had a histry f mycardial infarctin. Risk factrs included hypertensin in %, histry f diabetes mellitus in 19%, a family histry f heart disease in 7%, and a histry f cigarette smking in % (Table 1). Systemic hypthermia t a mean f 1.9 ::':::. C and hypthermic hyperkalemic cardiplegia (either antegrade r cmbined with retrgrade) was used in each patient (1% f patients with bld cardiplegia and 79% f patients with crystallid cardiplegia). The mean ttal bypass time and ttal ischemic time were.4 and 1.7 hurs, respectively. Frty-nine patients (.9%) needed intraartic balln cunterpulsatin either preperatively r pstperatively. Reperatin fr bleeding was required in 8.7% f the patients (46 patients). In this elderly grup, 7.8% f patients were underging secnd peratins and 4.4% f patients had a histry f a prir failed percutaneus transluminal crnary angiplasty. Three hundred three patients underwent islated crnary artery bypass grafting (CABG). The average number /94/$7.00

2 446 TSAI ET AL Ann Thrac Surg 1994;8:44-1 Table 1. Preperative Characteristics in Octgenarians Characteristic CABG (n = 0) AVR (n = 1) MVR (n = 4) MVRP (n = 1) DVR" (n = 0) Ttal (n = 8) Mean age (y) Sex (% male) NYHA (%) Class I & II Class III Class IV CAD extent (%) Symptms (%) CHF & dyspnea Unstable angina Histry f angina Abn exercise test Palpitatins Syncpe Cardiac arrest Histry f MI Risk factrs (%) Hypertensin Diabetes mellitus Family histry f heart disease < Smking Previus Current Abn ~abnrmal; AVR ~artic valve replacement with r withut CABG; CABG = crnary artery bypass grafting; CAD = crnary artery disease; CHF = cngestive heart failure; DVR+ = duble valve r cmbined prcedure with r withut CABG; MI = mycardial infarctin; MVR = mitral valve replacement with r withut CABG; MVRP ~mitral valve repair with CABG; NYHA = New Yrk Heart Assciatin. f grafts per patient was. ± 0.8, and % f the patients had received internal thracic artery grafts. A small number f patients had saphenus vein, arm vein, r crypreserved hmgraft vein (4 patients) as their bypass cnduit (Table ). Tw hundred twenty-five patients underwent valvular prcedures. The causes f valvular heart disease were as fllws: 4% were degenerative, 1.% had prlapse, % had papillary muscle infarctin r rupture, % had prsthetic dysfunctin, % were rheumatic, and.% had cngenital abnrmalities (Table ). A ttal f patients had valvular prcedures: 1 Table. Operative Prfiles in Octgenarians CABG AVR MVR MVRP DVR' Ttal Variable (n = 0) (n = 1) (n = 4) (n = 1) (n = 0) (n = 8) Hypthermia (mean C) Pump time (h) Ischemic time (h) IABP (n.) Rep fr bleeding (%) Red (%) Pst-PTCA (%) Cartid endarterectmy (%) Hspital stay (mean days) Years f fllw-up Number f grafts (mean) ITA (%) Prsthetic dysfunctin (n.) IABP ~intraartic balln pump; ITA ~internal thracic artery; PTCA ~percutaneus transluminal crnary angiplasty; Red ~reperatin; ther abbreviatins are as in Table 1.

3 Ann Thrac Surg 1994;8:44-1 TSAIET AL HEARTSURGERY IN ELDERLY 447 Table. Cause f Valvular Disease in Octgenarians (%) AVR MVR MVRP DVR+ All Cause (n = 1) (n = 4) (n = 1) (n = ) (n = 8) Degenerative Rheumatic 19 0 Papillary muscle MI r rupture Prsthetic dysfunctin Prlapse Cngenital All abbreviatins are as in Table 1. patients (8%) had tissue valves and 74 patients (%) had St. Jude prstheses. Furteen patients underwent Carpentier-Edwards mitral ring annulplasty and 17 patients had mitral suture annulplasty. Tricuspid annulplasty was perfrmed in 7 patients (6 with Carpentier-Edwards ring). Results Mrtality Thirty-day and in-hspital mrtality was 8.% fr the islated CABG grup (grup I), 4.% fr the artic valve replacement with/withut CABG grup (grup II), 9% fr the mitral valve replacement with/withut CABG grup (grup III), % fr the mitral valve repair with CABG grup (grup IV), and 0% fr the duble-valve r cmbined prcedure with/withut CABG grup (grup V). Ttal D-day r in-hspital mrtality was.6%. In refutatin f the ften-stated dictum that mrtality at this age is related t multisystem failure, 8 f the ttal 179 deaths, r 46%, were cardiac in nature. Estimatin f the causes f death revealed that 7 patients died f arrhythmia, f pump failure r cngestive heart failure, 14 f cerebrvascular accident, 1 f renal failure, 1 f pulmnary insufficiency, 1 f cancer, 6 f unknwn causes, f hemrrhage, and 4 f sudden death (Table 4). Surgical Cmplicatins Frty-ne percent f the patients had atrial fibrillatin and 19% had atrial flutter. Third degree heart blck requiring pacemaker implantatin develped in % (6 patients). Seven percent f the patients had pstperative mycardial infarctin (new Q waves n serial electrcardigrams). Furteen percent f the patients had pstperative cnfusin r disrientatin, and % f the patients had cerebrvascular accidents. Thirteen percent f the patients had pulmnary insufficiency. Leg infectin ccurred in 6%, and sternal wund infectin in %. Transient renal insufficiency (creatinine level greater than mg/dl) develped in 11% f the patients. Five patients required hemdialysis and patients died during their hspitalizatin. Six percent f the patients had sepsis and 4% had pericarditis. Survival One-year and -year pstperative actuarial survival rates were 8% and 6% fr the CABG, 86% and 8% fr the Table 4. Causes f Death in Octgenarians Wh Underwent Cardiac Operatin Cause (n.) Early Late Ttal Arrhythmia r presumed 1 7 Pump failure r CHF 8 4 Nncardiac Hemrrhage Pulmnary insufficiency 1 Sepsis 0 Cerebrvascular accident Mycardial infarctin 8 Pulmnary emblism 1 Renal failure Cardiac-nnvalvular 1 Cardiac rupture Cancer Endcarditis 0 Suicide 0 Trauma Sudden death Unknwn Ttal CHF = cngestive heart failure. artic valve replacement with/withut CABG grup, 61% and 7% fr the mitral valve replacement with/withut CABG grup, 6% and 19% fr the mitral valve repair with CABG grup, and 6% and 1% fr the duble-valve r cmbined prcedure with/withut CABG grup. Ttal I-year, -year and -year pstperative actuarial survival rates were 79%, 67%, and 4%, respectively (Table ). Table. Results f Cardiac Operatins in Octgenarians 0-Day & In-Hspital Actuarial Survival (%) Mrtality Prcedure (N.) (%) I-Year -Year -Year Grup I CABG (0) Grup II AVR (6) AVR + CABG (76) Sum (1) Grup III MVR (1) MVR + CABG (7) Sum (4) Grup IV MVRP + CABG (1) Grup V DVR' (7) DVR+ + CABG (1) Sum (0) Ttal (8) Abbreviatins are as in Table 1.

4 448 TSAI ET AL Ann Thrac Surg 1994;8:44-1 Percentage 80 Number f Cases CABG AVA MVA Fig 1. Quality f life in ctgenarian survivrs. (AVR = artic valve replacement; CABG = crnarv artery bypass grafting; MVR = mitral valve rcplaccmcnt.) Year Fig. Annual activity f cardiac peratins in ctgenarians. Quality f Life The fllw-up evaluatins included assessment f survival status, an evaluatin f general health as cmpared with that befre peratin (imprved, the same, r wrse) and an assessment f current level f activity (active, sedentary, r restricted). Seventy percent f the patients were shwn t be imprved, 18% remained unchanged and 1% deterirated (Fig 1). Thirty-eight percent f the patients led active lives, 6% f the patients were sedentary, and % were restricted in their daily activities-accrding t their respnses n a 6-mnth fllw-up questinnaire-fr a ttal mean f years' fllw-up. Cmment Mycardial Revascularizatin in Octgenarians The number f patients ver age 80 underging cardiac surgery is increasing yearly (Figs, ). As has been generally bserved in prir reprts f CABG in ctgenarians, mst patients in this age grup present with New Yrk Heart Assciatin functinal class III r IV symptms that are always refractry t mre cnservative Number f Patients _ c:::::::::j Number f Patients Earlymrtality (n) Percent Mrtality 0 Fig. Annual activity f crnary artery bypass peratins in ctgenarians thrugh a lo-year perid. 1 management [6-11]. In ur patient chrt, 6% f the patients were in class III and 7% were in class IV. In an therwise "healthy and viable" ctgenarian, the urgency f presentatin with unstable angina r lifethreatening symptms further cmpels perative interventin and has a significant impact n the perative mrtality rate. In the series reprted by Freeman and assciates [], the verall periperative mrtality rate was. times greater in patients having urgent versus elective prcedures. Emergency cardiac peratin in ctgenarians als has been shwn t be independently predictive f an increased periperative mrtality rate [7]. Khan and clleagues [1] stated that elderly patients perated n within 4 hurs after admissin had a mrtality rate equivalent t that f yunger patients and suggested that delays in treatment f elderly patients may adversely affect the utcme f peratin in the elderly. Clinical variables such as left ventricular ejectin fractin less than 0., New Yrk Heart Assciatin class IV, lw cardiac utput, r lw cardiac index preperatively were assciated with periperative mrtality [6]. Multiple studies have shwn that CABG in wmen clearly has a higher risk than in men [1]. Late referral fr bypass peratin has been suggested t be a significant cmpnent. In ur wn series we fund that patient sex (66% male) did nt influence early pstperative survival (male, 7.8%, versus female, 7.0%). Left main crnary disease was relatively cmmn (%) in this study grup; hwever, it was less frequently assciated with perative mrtality than in larger series f yung patients underging CABG []. Nearly all patients in this series had significant preperative symptmatic limitatin. Hwever, there was significant imprvement in general cnditin at fllw-up evaluatin. The actuarial survival rate f all patients in the current study discharged frm the hspital after cardiac peratin was significantly better than that f age and sex-matched cntrl ctgenarians []. Pstperative cmplicatins have been shwn t have independent variables influencing lng-term survival after CABG, especially arrhythmia [14] and cerebrvascular accident []. There was a substantial percentage (4%) in ~ t,.. J L..... & = -.. I L a. ~ l =... a L J L. - J L L J -. u.... a L.. L.. - L J 1 ~ 1 ~ 1 ~ 1 ~ 1 ~ l m 1 ~ 1 ~ 1 ~ l m 1 m Year

5 Ann Thrae Surg 1994;8:44-1 TSA1 ET AL 449 whm majr cmplicatins develped during the early pstperative perid. In ur 61 late nnsurvivrs, causes f death were cngestive heart failure in 16, arrhythmia r presumed arrhythmia in 14, renal failure in 14, pulmnary insufficiency in 9, cancer in 9, and cerebrvascular accident in 7. Valve Repair r Replacement and Cmbined Prcedures in Octgenarians Fr elective valvular peratins, the type f cardiac surgical prcedure clearly influences periperative mrtality [7, 11, 1]. Islated artic valve replacement had the lwest mrtality rate (1.8%), which increased with cncmitant CABG (6.6%). The ttal perative mrtality rate was 4.% in the artic valve replacement with r withut CABG grup. The periperative mrtality rate was clearly higher in patients underging mitral valve peratins: 0% fr islated mitral valve replacement, % fr mitral valve repair with CABG, and % fr mitral valve replacement with CABG. The ttal perative mrtality was 9% fr the mitral valve replacement with r withut CABG grup. Hwever, the mst cmmn cause fund in ur 7 patients with mitral valvular disease was degenerative (9%). Operatin was recmmended in patients with severe mitral valvular symptms; if minimal symptms were evident, it was recmmended nly in the case f deteriratin f ventricular functin r cardiac enlargement [16]. If repair was nt technically feasible, replacement was perfrmed with preservatin f the mitral valve apparatus [17]. In ur series, 1 patients underwent mitral valve repair with CABG, either using suture annulplasty (Kay Zubiate type) (17 patients) r Carpentier-Edwards ring annulplasty (14 patients), with a periperative mrtality rate f %. There were 4 patients wh underwent mitral valve replacement, mst f them with the subvalvular apparatus preserved, with a periperative mrtality rate f 9%. N statistical difference between these tw prcedures in mrtality and mrbidity was nted. The durability f mitral repair exceeds the expected life span f the ctgenarian. This fact, cupled with the avidance f anticagulatin, made mitral valve recnstructin an ideal prcedure in this age grup [18, 19]. Fr mre than tw valve prcedures, the perative mrtality rate was 14% fr duble-valve prcedures and 9% fr duble-valve prcedures cmbined with CABG bypass; the ttal mrtality rate was 0%. Of all prcedures, nly mitral valve peratin (especially fr severe ischemic mitral regurgitatin) was significantly assciated with an increased perative mrtality rate [0]. Mitral valve peratin als has been identified previusly as an independent risk factr fr perative mrtality in elderly patients [1, ]. The hemdynamics f the St. Jude mechanical valves in use (74 patients), favred their use in the small artic rt, as hydraulic functin was significantly imprved cmpared with the prcine biprsthesis []. The newly apprved Carpentier-Edwards pericardial valve als prvided excellent hydraulic functin, and experience t date suggests it is durable and als suitable in the smaller artic rt [4]. Brkn and assciates [] reprted a threefld increase in anticagulant-related bleeding in patients mre than 70 years ld with implantatin f mechanical valves. Frtunately, the increased incidence f bleeding was nt assciated with an increased incidence f mrtality. The plicy f using bilgic valves in ctgenarians, if pssible (68% in ur series), wuld seem beneficial because it bviates life-lng anticagulatin with warfarin. The ttal fllw-up mrtality rate (early and late) was 7.% in the mechanical valve replacement grup versus 0.% in tissue valve replacement grup. Biprsthetic valves may be much mre durable in the elderly than in yunger ppulatins. In the ctgenarian, the durability f the biprsthetic valve clearly exceeds expected survival. When valve replacement is indicated and anticagulatin can be avided, a biprsthetic valve appears t be the best chice, prvided a suitable size can be implanted [, 6]. Mst deaths were f cardiac rigin (48%), with the majrity due t lw cardiac utput state, pstperative mycardial infarctin, and arrhythmia. Hwever, nncardiac event, cancer, pulmnary insufficiency, cerebrvascular accident, and chrnic renal failure were respnsible fr a significant percentage f the late deaths (46%) [7, 1]. Frm 4% t 8% f the survivrs were fund t be imprved as cmpared with their preperative status at the time f fllw-up. It is significant that nearly all f the patients were gravely decmpensated and in New Yrk Heart Assciatin class III r IV befre peratin (98% were in New Yrk Heart Assciatin class III and IV). Table 6. Survival Cmparisn Acrss Age Grups Survivrs Age Mre Than Age Years 80 Years p Grup Number Percent Number Percent Value CABG year 1, year AVR year year AVR + CABG year year MVR; MVR CABG 1 year year 1 7 MVRP;MVRP CABG 1 year year DVR;DVR CABG 1 year year All patients year 1, year Abbreviatins are as in Table 1.

6 TSAI ET AL Ann Thrac Surg 1994;8:44-1 Cnclusins Elective cardiac peratins can be perfrmed in selected patients aged mre than 80 years with acceptable periperative mrtality 00.6%) r mrbidity and with anticipatin f significantly imprved symptmatic status (70%) and pssibly increased lngevity. In cmparing the survival prbability acrss the septuagenarian age grup (70 t 79 years), there is a statistically significant difference in septuagenarians wh underwent islated CABG (p = ) and mitral valvular peratins (p = 0.07) (Table 6). Early mrtality is least with elective islated artic valve replacement (1.8%) and islated CABG (8.%) but is greatest in peratins fr mitral regurgitatin. Clinical evidence f preperative left ventricular failure, functinal class IV symptms, and urgent surgical prcedures are assciated with increased periperative mrtality. The decisin regarding whether r nt an ctgenarian shuld underg a cardiac peratin shuld be made with an pen discussin by the treating physician, the cardilgist, the cardiac anesthesilgist, the cardiac surgen, the patient, and the patient's family. Whenever feasible, these patients shuld be in stable cnditin befre underging peratin. Severely symptmatic ctgenarians shuld nt be denied the benefit f a cardiac peratin if they are reasnably gd surgical candidates with gd physical and mental health. We thank Kathleen Farringtn fr her secretarial assistance in the preparatin f the manuscript, and Phyllis Crise, Varujan Kash, Rmmel Del Rsari, Michele DeRbertis, and Thmas Salciccia fr their technical assistance. References 1. Statistical abstract f the United States: 1991 (Ll lth ed). Washingtn, DC: US Bureau f the Census, 1991:81.. Natinal Center fr Health Statistics. United States life tables: US decennial life tables fr , vl 1, n 1. Washingtn, DC: Gvernment Printing Office, 198 (DHHS publicatin (PHS) 8-1-1).. Freeman WK, Schaff HV, O'Brien PC, et al. Cardiac surgery in the ctgenarian: periperative utcme and clinical fllwup. J Am Cll Cardil 1991;18: K W, Krieger KH, Lazenby WD, et al. Islated crnary artery bypass grafting in ne hundred cnsecutive ctgenarian patients. J Thrac Cardivasc Surg 1991;:-8.. Weintraum WS, Craver JM, Chen CL, et al. Influence f age n results f crnary artery surgery. Circulatin 1991; 84(Suppl ): Tsai TP, Nessim, Chaux A, et al. Mrbidity and mrtality after crnary artery bypass in ctgenarians. Ann Thrac Surg 1991;1: Cullifrd AF, Gallway AC, Clvin SB, et al. Artic valve replacement fr artic stensis in persns aged 80 years and ver. Am J Cardil 1991;67: Tsai TP, Chaux A, Kass R, et al. Cardiac valvular surgery in 1 ctgenarians. Chest 1991;0:1. 9. Kleikamp G, Minami K, Breymann T, et al. Artic valve replacement in ctgenarians. J Heart Valve Dis 199;1: Khan, Kupfer JM, Matlff JM, et al. Interactin f age and preperative risk factrs in predicting perative mrtality fr crnary bypass surgery. Circulatin 199;86(SuppI): Tsai TP, Matlff JM, Gray RJ, et al. Cardiac surgery in the ctgenarian. J Thrac Cardivasc Surg 1986;91: Khan, Kupfer JM, Matlff JM, et al. Hetergeneus mrtality rates f elderly patients underging crnary bypass surgery. Circulatin 199;86(Suppl 1): Glin A, Panza A, Vigrit C, et al. Mycardial revascularizatin in wmen. Tex Heart Inst J 1991;18: Lp FD, Lytle BW, Csgrve DM, et al. Crnary artery bypass graft surgery in the elderly: indicatins and utcme. Cleve Clin J Med 1988;: Fire AC, Naunheim KS, Barner HB, et al. Valve replacement in the ctgenarian. Ann Thrac Surg 1989;48: Assey ME. Indicatins fr heart valve replacement. Clin Cardil 1990;1: Miki, Kusuhara K, Ueda Y, et al. Mitral valve replacement with preservatin f chrdae tendineae and papillary muscles. Ann Thrac Surg 1988;4: Csgrve DM, Chavez AM, Lytle BW, et al. Results f mitral valve recnstructin. Circulatin 1986;74(Suppl 1): Gallway AC, Clvin SB, Baumann FG, et al. Lng-term results f mitral valve recnstructin with Carpentier techniques in 148 patients with mitral insufficiency. Circulatin 1988;78(Suppl 1): Czer LSC, Gray RJ, DeRbertis MA, et al. Mitral valve replacement: impact f crnary artery disease and determinants f prgnsis after revascularizatin. Circulatin 1984;70(Suppl 1): Fremes SE, Gldman BS, Ivanv J, et al. Valvular surgery in the elderly. Circulatin 1989;80(Suppl 1): Tsai TP, Matlff JM, Chaux A, et al. Cmbined valve and crnary artery bypass prcedures in septuagenarians and ctgenarians: results in 10 patients. Ann Thrac Surg 1986; 4: Czer LSC, Matlff JM, Chaux A, et al. Cmparative clinical experience with prcine biprsthetic and St. Jude valve replacement. Chest 1987;91: Bessne LN, Pupell DF, Hir SP, et al. Surgical management f artic valve disease in the elderly: a lngitudinal analysis. Ann Thrac Surg 1988;46: Brkn AM, Sule LM, Baughman KL, et al. Artic valve selectin in the elderly patient. Ann Thrac Surg 1988;46: Jamiesn WRE, Burr LH, Munr AI, et al. Cardiac valve perfrmance in the elderly: clinical perfrmance f bilgic prstheses. Ann Thrac Surg 1989;48:17-8. INVITED COMMENTARY This reprt accurately dcuments the fact that elderly patients, especially thse 80 years ld and lder, are being referred fr pen heart peratins mre frequently, reflecting the increase in the very elderly prtin f the ppulatin as well as the excellent utcme seen with heart peratins in yunger patients. Many peple, bth medical prfessinals and the lay public, hwever, are questining the apprpriateness f such majr surgical prcedures in individuals with limited life expectancies. In the cntext f such skepticism abut peratins in elderly individuals,

Cardiac Rehabilitation Services

Cardiac Rehabilitation Services Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019

More information

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline) Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting

More information

CLINICAL EXPERIENCE WITH THE CARBOMEDICS VALVE: EARLY RESULTS WITH A NEW BILEAFLET MECHANICAL PROSTHESIS

CLINICAL EXPERIENCE WITH THE CARBOMEDICS VALVE: EARLY RESULTS WITH A NEW BILEAFLET MECHANICAL PROSTHESIS CLINICAL EXPERIENCE WITH THE CARBMEDICS VALVE: EARLY RESULTS WITH A NEW BILEAFLET MECHANICAL PRSTHESIS J. Francisc Nistal, MD Aquilin Hurl6, MD Js6 M. Revuelta, MD Marc Gandarillas, PhD* Between January

More information

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent

More information

CDC Influenza Division Key Points MMWR Updates February 20, 2014

CDC Influenza Division Key Points MMWR Updates February 20, 2014 CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February

More information

CDC Influenza Technical Key Points February 15, 2018

CDC Influenza Technical Key Points February 15, 2018 CDC Influenza Technical Key Pints In this dcument: Summary Key Pints U.S. Vaccine Effectiveness U.S. Flu Activity Update Summary Key Pints On Thursday, tw influenza-related reprts appeared in the Mrbidity

More information

Coronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070)

Coronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070) Crnary Artery Disease (CAD): Beta Blcker Therapy fr CAD Patients with Prir Mycardial Infarctin (MI) (NQF 0070) EMeasure Name Crnary Artery Disease EMeasure Id Pending (CAD): Beta Blcker Therapy fr CAD

More information

Osteoporosis Fast Facts

Osteoporosis Fast Facts Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased

More information

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by ESTIMATION PROCEDURES USED TO PRODUCE WEEKLY FLU STATISTICS FROM THE HEALTH INTERVIEW SURVEY James T. Massey, Gail S. Pe, Walt R. Simmns Natinal Center fr Health Statistics. INTRODUCTION In April 97, the

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

High Performance Network Quality Criteria for Designation

High Performance Network Quality Criteria for Designation Selected quality measures include: Specialty Measure Descriptin Allergy / Immunlgy Asthma Drug Mgt Vaccine Pneumnia Vaccine High Perfrmance Netwrk Quality Criteria fr Designatin AvMed has selected certain

More information

Neurological outcome from conservative or surgical treatment of cervical spinal cord injured patients

Neurological outcome from conservative or surgical treatment of cervical spinal cord injured patients 1993 nternatinal Medical Sciety f Paraplegia eurlgical utcme frm cnservative r surgical treatment f cervical spinal crd injured patients J E Kiwerski Spinal Department f Metrplitan Rehabilitatin Centre,

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information

Commissioning Policy: South Warwickshire CCG (SWCCG)

Commissioning Policy: South Warwickshire CCG (SWCCG) Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding

More information

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this

More information

CDC Influenza Division Key Points November 7, 2014

CDC Influenza Division Key Points November 7, 2014 In this dcument: Summary Key Messages FluView Activity Update LAIV Effectiveness and Vaccinatin f Children H3N2 Match and Vaccinatin Vaccine Supply Summary Key Messages This week s FluView reprt indicates

More information

NQF 0075 Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control

NQF 0075 Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control NQF 0075 Ischemic Vascular Disease (IVD): Cmplete Lipid Panel and LDL Cntrl Initial Patient Ppulatin: Numeratr(1): Numeratr(2): N Exclusin: Denminatr: D Exceptin: D Exclusin: Patients 18 years f age and

More information

WARNING: FATAL AND SERIOUS TOXICITIES: SEVERE DIARRHEA AND CARDIAC TOXICITIES

WARNING: FATAL AND SERIOUS TOXICITIES: SEVERE DIARRHEA AND CARDIAC TOXICITIES INDICATION FARYDAK (panbinstat) capsules, a histne deacetylase inhibitr, in cmbinatin with brtezmib and dexamethasne, is indicated fr the treatment f patients with multiple myelma wh have received at least

More information

Ontario s Referral and Listing Criteria for Adult Lung Transplantation

Ontario s Referral and Listing Criteria for Adult Lung Transplantation Ontari s Referral and Listing Criteria fr Adult Lung Transplantatin Versin 2.0 Trillium Gift f Life Netwrk Adult Lung Transplantatin Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The patient referral

More information

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder? updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health

More information

Referral Criteria: Inflammation of the Spine Feb

Referral Criteria: Inflammation of the Spine Feb Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses

More information

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or Heart Failure (HF): Angitensin Cnverting Enzyme (ACE) Inhibitr r Angitensin Receptr Blcker (ARB) Therapy fr Left Ventricular Systlic Dysfunctin (LVSD) (NQF 0081) EMeasure Name Heart Failure (HF): Angitensin

More information

The principles of evidence-based medicine

The principles of evidence-based medicine The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t

More information

Patterns of Cholesterol Distribution in the Participants of a Screening Project

Patterns of Cholesterol Distribution in the Participants of a Screening Project Patterns f Chlesterl Distributin in the Participants f a Screening Prject Abdul Hamid Shaikh, S With guidelines similar t thse recmmended by the Natinal Chlesterl Educatin Prgram (NCEP), 3,3 individuals

More information

Clinical Study Synopsis

Clinical Study Synopsis Clinical Study Synpsis This Clinical Study Synpsis is prvided fr patients and healthcare prfessinals t increase the transparency f Bayer's clinical research. This dcument is nt intended t replace the advice

More information

Ischemic heart disease (angina/chest pain)

Ischemic heart disease (angina/chest pain) Ischemic heart disease (angina/chest pain) External resurces Stable angina: management NICE guidelines [CG126] Updated :Aug 2016 https://www.nice.rg.uk/guidance/cg126 Chest pain f recent nset [CG95] Nvember

More information

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select

More information

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or Heart Failure (HF): Angitensin Cnverting Enzyme (ACE) Inhibitr r Angitensin Receptr Blcker (ARB) Therapy fr Left Ventricular Systlic Dysfunctin (LVSD) (NQF 0081) EMeasure Name Heart Failure (HF): EMeasure

More information

Itay Perets, MD Lyall Ashberg, MD Edwin O. Chaharbakhshi, BS, John P. Walsh, MA Mary R. Close, BS Benjamin G. Domb, MD. Hinsdale Orthopaedics

Itay Perets, MD Lyall Ashberg, MD Edwin O. Chaharbakhshi, BS, John P. Walsh, MA Mary R. Close, BS Benjamin G. Domb, MD. Hinsdale Orthopaedics Clinical utcmes and return t sprt in cmpetitive athletes underging ilipsas fractinal lengthening as a part f hip arthrscpy minimum 2 year fllw-up Itay Perets, MD Lyall Ashberg, MD Edwin O. Chaharbakhshi,

More information

Motor Vehicle Accidents in Patients With an Implantable Cardioverter-Defibrillator

Motor Vehicle Accidents in Patients With an Implantable Cardioverter-Defibrillator 180 JACC Vl. 26, N. 1 July 1995:180-4 Mtr Vehicle in Patients With an Implantable Cardiverter-Defibrillatr ANNE B. CURTIS, MD, FACC, JAMIE B. CONTI, MD, FACC, KELLY J. TUCKER, MD, PAUL S. KUBILIS, MS,

More information

Solid Organ Transplant Benefits to Change for Texas Medicaid

Solid Organ Transplant Benefits to Change for Texas Medicaid Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a

More information

The data refer to persons aged between 15 and 54.

The data refer to persons aged between 15 and 54. Drug-related hspital stays in Australia 1993-2005 Prepared by Amanda Rxburgh and Luisa Degenhardt, Natinal Drug and Alchl Research Centre Funded by the Australian Gvernment Department f Health and Ageing

More information

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin Service Change Prcess Gateway 1 High-level Prpsitin Innvatin prject name: Patient Self-Mnitring/Management f Warfarin NHS Bury Please describe the service change being prpsed. Please describe what service(s)

More information

Influenza (Flu) Fact Sheet

Influenza (Flu) Fact Sheet Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder

More information

Adult Preventive Care Guidelines

Adult Preventive Care Guidelines Adult Preventive Care Guidelines Gundersen is yur partner fr better health. We want t wrk with yu t make sure that yu and yur family are as healthy as pssible. That can be accmplished best if we wrk tgether

More information

Human papillomavirus (HPV) refers to a group of more than 150 related viruses.

Human papillomavirus (HPV) refers to a group of more than 150 related viruses. HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between

More information

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,

More information

WHAT IS HEAD AND NECK CANCER FACT SHEET

WHAT IS HEAD AND NECK CANCER FACT SHEET WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice

More information

Cambridge Breast Unit Protocols for anticoagulant management prior to breast or axillary biopsies or excisions.

Cambridge Breast Unit Protocols for anticoagulant management prior to breast or axillary biopsies or excisions. Prtcl CBU/POL/ JOINT POLICIES/008 Octber 2017 Prtcls fr anticagulant management prir t breast r axillary bipsies r excisins. 1. Scpe Fr use in the in bth screening and symptmatic breast services. 2. Purpse

More information

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10 Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family

More information

Risk factors in health and disease

Risk factors in health and disease Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk

More information

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain Pennsylvania Guidelines n the Use f Opiids t Treat Chrnic Nncancer Pain Chrnic pain is a majr health prblem in the United States, ccurring with a pintprevalence f abut ne-third f the US ppulatin.(1) Mre

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is

More information

Related Policies None

Related Policies None Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER

More information

Echocardiography Diagnostic Accuracy

Echocardiography Diagnostic Accuracy Echcardigraphy Diagnstic Accuracy Measure Descriptin: The prprtin f ptentially preventable and clinically imprtant inaccurate diagnses amng cngenital heart surgical patients. Numeratr Number f cngenital

More information

Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα

Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα Γ. Λάζαρος Επιμελητής Α Α Πανεπιστημιακή Καρδιολογική Κλινική Ιπποκράτειο Γ.Ν.Α The nrmal pericardium is

More information

decreased when the man lies down. The varicocele cannot usually be palpated lying down.

decreased when the man lies down. The varicocele cannot usually be palpated lying down. Variccele - Management View full scenari Hw d I knw my patient has a variccele? The man may present with cncern abut scrtal swelling r scrtal pain, r a variccele may be an incidental finding n physical

More information

Safety of HPV vaccination: A FIGO STATEMENT

Safety of HPV vaccination: A FIGO STATEMENT FIGO Statement n HPV Vaccinatin Safety, August 2nd, 2013 Safety f HPV vaccinatin: A FIGO STATEMENT July, 2013 Human papillmavirus vaccines are used in many cuntries; glbally, mre than 175 millin dses have

More information

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Surgery Instructions Hip

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Surgery Instructions Hip Patrick J McGahan, MD Orthpaedic Surgen Specializing in Sprts Medicine/Shulder Recnstructin 2801 K St, Ste 330, Sacrament, CA, 95816 (p) 916-733-5049 (f) 916-733-8914 www.patrickmcgahanmd.cm Befre Surgery

More information

Transcatheter Aortic Valve Implantation for Aortic Stenosis

Transcatheter Aortic Valve Implantation for Aortic Stenosis MEDICAL POLICY 7.01.132 Transcatheter Artic Valve Implantatin fr Artic Stensis BCBSA Ref. Plicy: 7.01.132 Effective Date: May 1, 2017 Last Revised: Oct. 24, 2017 Replaces: N/A RELATED MEDICAL POLICIES:

More information

Emergency Department Performance Measures

Emergency Department Performance Measures Emergency Department Perfrmance Measures ACEP Clinical Emergency Data Registry () ACEP Campaign Centers fr Medicare and Medicaid Services (CMS) Medicare Beneficiary Quality Imprvement Prject (MBQIP) ED

More information

Significance of Chronic Kidney Disease in 2015

Significance of Chronic Kidney Disease in 2015 1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care

More information

Measure Information Form

Measure Information Form Release Ntes: Measure Infrmatin Frm Versin 2.0 **NQF-ENDORSED VOLUNTRY CONSENSUS STNDRDS FOR HOSPITL CRE** Measure Set: Heart Failure (HF) Set Measure ID#: Measure Infrmatin Frm Perfrmance Measure Name:

More information

PET FORM Planning and Evaluation Tracking ( Assessment Period)

PET FORM Planning and Evaluation Tracking ( Assessment Period) Divisin f: Behaviral Studies PET FORM Planning and Evaluatin Tracking (2010 2011 Assessment Perid) Persn Respnsible fr this Divisin: Jerry Mller Department f: Behaviral Sciences Persn Respnsible fr this

More information

ACEM Fellowship Examination Emergency Medicine Practice Questions SAQ

ACEM Fellowship Examination Emergency Medicine Practice Questions SAQ ACEM Fellwship Examinatin Emergency Medicine 2014-15 Practice Questins SAQ SAQ Questin 1 (16 minutes) a) List the pssible causes f the child s death (30%) b) Describe in detail yur verall management f

More information

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment

More information

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED

More information

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights. HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,

More information

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning Plicy Guidelines: Genetic Testing fr Carrier Screening and Reprductive Planning Cntents Overview... 1 Cverage guidelines... 2 General cverage guidelines... 2 Rutine carrier screening... 2 Carrier screening

More information

Lifestyle Modification Program for Reversing Heart Disease Effective Date November 26, 2014

Lifestyle Modification Program for Reversing Heart Disease Effective Date November 26, 2014 Medical Plicy BSC8.01 Sectin 8.0 Therapy Subsectin Lifestyle Mdificatin Prgram fr Reversing Heart Disease Effective Date Nvember 26, 2014 Original Plicy Date Nvember 26, 2014 Next Review Date Nvember 2015

More information

Waterloo Wellington Rehabilitative Care System Integrated Care Pathway for STROKE Stream of Care HYPERACUTE URGENT TIA and SECONDARY STROKE PREVENTION

Waterloo Wellington Rehabilitative Care System Integrated Care Pathway for STROKE Stream of Care HYPERACUTE URGENT TIA and SECONDARY STROKE PREVENTION Waterl Wellingtn Rehabilitative Care System Integrated Care Pathway fr STROKE Stream f Care HYPERACUTE URGENT TIA and SECONDARY STROKE PREVENTION Care Setting Activity Patients wh present t a cmmunity

More information

A. Catalonia World Health Organization Demonstration Project

A. Catalonia World Health Organization Demonstration Project A. Catalnia Wrld Health Organizatin Demnstratin Prject In 1989, the Health Department f Catalnia (Spain) and the Cancer Unit at the WHO (Geneva) designed and planned a demnstratin prject fr implementatin

More information

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review: Bedfrdshire and Hertfrdshire DRAFT Pririties frum statement Number: Subject: Prstatism Date f decisin: January 2010 Date f review: Referral criteria Mst men with lwer urinary tract symptms due t benign

More information

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health

More information

Center for Circulatory Support. The Center for Circulatory Support strives for continuous improvement in quality and patient outcomes

Center for Circulatory Support. The Center for Circulatory Support strives for continuous improvement in quality and patient outcomes Palliative Care Cnsults: Centers fr Medicare and Medicaid Services Decisin Mem fr Ventricular Assist Devices fr Bridge-t-Transplant and Destinatin Therapy Center fr Circulatry Supprt The Center fr Circulatry

More information

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

ACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals.

ACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals. 27 March 2014 Prfessr Debra Picne Chief Executive Officer Australian Cmmissin n Safety and Quality in Health Care c/ Ms Jennifer Hill, Senir Prject Officer Level 5, 255 Elizabeth Street SYDNEY NSW 2000

More information

Original Policy Date

Original Policy Date MP 7.03.08 Heart Transplant Medical Plicy Sectin Surgery Issue 12/2013 Original Plicy Date 12/2013 Last Review Status/Date Reviewed with literature search/12/2013 Return t Medical Plicy Index Disclaimer

More information

M.R.C.Path. causes to the raised plasma urea in patients admitted

M.R.C.Path. causes to the raised plasma urea in patients admitted Pstgradcuate Medical Jurnal (January 1979) 55, 1-14 The cause f the raised plasma urea f acute heart failure R D THOMAS MRCP D B MORGAN MRCPath ALISON NWILL AIMLS Departments f Cardilgy and Chemical Pathlgy,

More information

Cardiac Rehabilitation in the Outpatient Setting Section 8.0 Therapy Subsection 8.03 Rehabilitation

Cardiac Rehabilitation in the Outpatient Setting Section 8.0 Therapy Subsection 8.03 Rehabilitation 8.03.08 Cardiac Rehabilitatin in the Outpatient Setting Sectin 8.0 Therapy Subsectin 8.03 Rehabilitatin Effective Date February 15, 2015 Original Plicy Date September 13, 1989 Next Review Date December

More information

Stroke A Journal of Cerebral Circulation

Stroke A Journal of Cerebral Circulation A Jurnal f Cerebral Circulatin NOVEMBER-DECEMBER 1971 VOL. 2 NO. 6 Cerebrvascular Disease in the Bi-Racial Ppulatin f Evans Cunty, Gergia BY A. HEYMAN, M.D., H. R. KARP, M.D., S. HEYDEN, M.D., A. BARTEL,

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. Over the last several mnths, the United States has experienced a natinwide utbreak f entervirus D68 (EV- D68) assciated

More information

Chapter 6: Impact Indicators

Chapter 6: Impact Indicators Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. The United States is currently experiencing a natinwide utbreak f entervirus D68 (EV-D68) assciated with severe

More information

Flu Season Key Points ( )

Flu Season Key Points ( ) 2014-2015 Flu Seasn Key Pints (10-31-14) Cntents Overarching Framewrk f CDC Influenza Messaging... 3 Take 3 Messages... 3 Statements fr General Audiences... 4 Disease... 4 Vaccinatin... 6 Vaccinatin Timing...

More information

Introduction to Psychological Disorders (Myers for AP 2 nd Edition, Module 65)

Introduction to Psychological Disorders (Myers for AP 2 nd Edition, Module 65) Intrductin t Psychlgical Disrders (Myers fr AP 2 nd Editin, Mdule 65) Why are we s interested in learning abut psychlgical disrders? The Wrld Health Organizatin reprts that peple suffer frm mental r behavir

More information

Annex III. Amendments to relevant sections of the Product Information

Annex III. Amendments to relevant sections of the Product Information Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t

More information

Kent and Medway Policy Recommendation and Guidance Committee Policy Recommendation

Kent and Medway Policy Recommendation and Guidance Committee Policy Recommendation Kent and Medway Plicy Recmmendatin and Guidance Cmmittee Plicy Recmmendatin Plicy: PR 2017-11: Surgery fr haemrrhids Issue date: July 2017 Review date: July 2020 The Kent and Medway Plicy Recmmendatin

More information

Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information

Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information Structured Assessment using Multiple Patient Scenaris (StAMPS) Exam Infrmatin 1. Preparing fr the StAMPS assessment prcess StAMPS is an assessment mdality that is designed t test higher rder functins in

More information

QUALITY AND SAFETY MEASURES UPDATE January 2016

QUALITY AND SAFETY MEASURES UPDATE January 2016 CLINICAL EFFECTIVENESS/SAFETY M CORE MEASURES 2015 See attached Results QUALITY AND SAFETY MEASURES UPDATE January 2016 Jint Cmmissin and CMS Cre Measure Dashbard updated with mst recent data available:

More information

Advance Care Planning Collaboration 101

Advance Care Planning Collaboration 101 Advance Care Planning Cllabratin 101 Stephanie VanSlyke, RN ACP Facilitatr Ethics Cnsultant Michigan Hme Care & Hspice Assciatin Overview Defining the prcess f Advance Care Planning (ACP) Why is ACP imprtant?

More information

CDC Influenza Division Key Points December 9, 2016

CDC Influenza Division Key Points December 9, 2016 In this dcument: Summary Key Pints Summary f Influenza Virus Labratry Data FluView Activity Update Early Influenza Vaccine Cverage Estimates fr 2016-17 Influenza Vaccine Prgram Impact Estimates fr 2015-16

More information

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP Cntinuus Psitive Airway Pressure (CPAP) and Respiratry Assist Devices (RADs), Including Bi-Level PAP Benefit Criteria t Change fr Texas Medicaid Effective March 1, 2017 Overview f Benefit Changes Benefit

More information

BRCA1 and BRCA2 Mutations

BRCA1 and BRCA2 Mutations BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease

More information

Percutaneous Nephrolithotomy (PCNL)

Percutaneous Nephrolithotomy (PCNL) Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this

More information

FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR COMPUTED TOMOGRAPHY:

FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR COMPUTED TOMOGRAPHY: Natinal Imaging Assciates, Inc. Clinical guideline CT HEART CT HEART Cngenital (Nt including crnary arteries) Original Date: September 1997 Page 1 f 10 CPT Cdes: 75572, 75573 Last Reviewed Date: September

More information

Indications and Limitations of Coverage and/or Medical back to top

Indications and Limitations of Coverage and/or Medical back to top Fr services perfrmed n r after 09/15/2009 Original Determinatin Ending Date Revisin Effective Date Revisin Ending Date Indicatins and Limitatins f Cverage and/r Medical Necessity Indicatins Medicare cverage

More information

National Imaging Associates, Inc. Clinical guideline:

National Imaging Associates, Inc. Clinical guideline: Natinal Imaging Assciates, Inc. Clinical guideline: Original Date: Octber 6, 2009 CT CORONARY ANGIOGRAPHY () Page 1 f 14 CPT Cdes: 75574 Last Reviewed Date: July 2013 Guideline Number: NIA_CG_062 Last

More information

DRAFT Policy for the Management of Ear Wax

DRAFT Policy for the Management of Ear Wax Clinical Cmmissining Grup (CCG) Treatment Plicy NHS Birmingham and Slihull Clinical Cmmissining Grup NHS Sandwell and West Birmingham Clinical Cmmissining Grup DRAFT Plicy fr the Management f Ear Wax 1

More information

Anterior Total Hip Arthroplasty Patient Guide & Common Questions

Anterior Total Hip Arthroplasty Patient Guide & Common Questions Intrductin: Anterir Ttal Hip Arthrplasty Patient Guide & Cmmn Questins This handut is a general guide t cmmn indicatins fr anterir ttal hip arthrplasty, what t expect when underging the prcedure, risks,

More information

Frequently Asked Questions: IS RT-Q-PCR Testing

Frequently Asked Questions: IS RT-Q-PCR Testing Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld

More information

Improving Surveillance and Monitoring of Self-harm in Irish Prisons

Improving Surveillance and Monitoring of Self-harm in Irish Prisons HSE Mental Health Divisin Stewart s Hspital, Palmerstwn, Dublin 20 Tel: 01 6201670 Email: inf@nsp.ie www.nsp.ie Imprving Surveillance and Mnitring f Self-harm in Irish Prisns Prject Scpe Dcument 8 th June

More information

2017 Optum, Inc. All rights reserved BH1124_112017

2017 Optum, Inc. All rights reserved BH1124_112017 1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases

More information

Smoking Cessation Improvement in SFHN Primary Care,

Smoking Cessation Improvement in SFHN Primary Care, Smking Cessatin Imprvement in SFHN Primary Care, 2015-16 David Silven, PhD, Supervising Psychlgist, SFHN Primary Care Behaviral Health Ellen Chen, MD, Directr f Quality, SFHN Primary Care Why smking assessment

More information

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

Body Weight, Cerebral Atherosclerosis and Cerebral Vascular Disease: An Autopsy Study

Body Weight, Cerebral Atherosclerosis and Cerebral Vascular Disease: An Autopsy Study Bdy Weight, Cerebral Athersclersis and Cerebral Vascular Disease: An Autpsy Study BY A. C. KLASSEN, M.D., R. B. LOEWENSON, Ph.D., AND J. A. RESCH, M.D. Abstract: Bdy Weight, Cerebral A thersclersis and

More information

US Public Health Service Clinical Practice Guidelines for PrEP

US Public Health Service Clinical Practice Guidelines for PrEP Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S

More information

Health for Life Chiropractic At Cloverdale Mall Unit # The East Mall Etobicoke, ON, M9B 3Y

Health for Life Chiropractic At Cloverdale Mall Unit # The East Mall Etobicoke, ON, M9B 3Y Health fr Life Chirpractic At Clverdale Mall Unit #143-250 The East Mall Etbicke, ON, M9B 3Y8 416-232-1822 416-232-0060 Child and Adlescent Health Questinnaire Name:_ Birth date: Address:_ Telephne: Medical

More information